This study was undertaken with the goal of determining whether the clinical differences among the various AML oncogenes are reflected in different modes of transformation in vitro using primary human CD34+ cells, and whether early in vitro gene expression profiling can shed light on mechanisms of leukemogenesis. Here, CD34 is linked to acute myeloid leukemia.